NEMO Prevents Steatohepatitis and Hepatocellular Carcinoma by Inhibiting RIPK1 Kinase Activity-Mediated Hepatocyte Apoptosis

Cancer Cell - United States
doi 10.1016/j.ccell.2015.10.001
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

OTULIN Prevents Liver Inflammation and Hepatocellular Carcinoma by Inhibiting FADD- And RIPK1 Kinase-Mediated Hepatocyte Apoptosis

Cell Reports
BiochemistryGeneticsMolecular Biology
2020English

Fasting Induces Hepatocellular Carcinoma Cell Apoptosis by Inhibiting SET8 Expression

Oxidative Medicine and Cellular Longevity
BiochemistryMedicineCell BiologyAging
2020English

Death-Domain Dimerization-Mediated Activation of RIPK1 Controls Necroptosis and RIPK1-dependent Apoptosis

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2018English

Kinase-Independent Functions of RIPK1 Regulate Hepatocyte Survival and Liver Carcinogenesis

Journal of Clinical Investigation
Medicine
2017English

JCAD Promotes Progression of Non-Alcoholic Steatohepatitis to Liver Cancer by Inhibiting LATS2 Kinase Activity

Cancer Research
Cancer ResearchOncology
2017English

Hepatocyte-Specific Pten Deficiency Results in Steatohepatitis and Hepatocellular Carcinomas

Journal of Clinical Investigation
Medicine
2004English

Β-Arrestin 2 Promotes Hepatocyte Apoptosis by Inhibiting Akt Protein

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2015English

Hepatocellular Carcinoma: Immunohistochemical Characteristics of Apoptosis and Cell Proliferation Activity.

Morphologia
2014English

Inhibitor of Apoptosis Proteins (Iaps) Limit Ripk1 Mediated Skin Inflammation

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy